What did H.I.G. Capital pay for St. Croix Hospice?

H.I.G. Capital acquired St. Croix Hospice for $580.0M in 2020 (15.5x EBITDA). Target EBITDA was approximately $37.5M.

What does St. Croix Hospice do?

St. Croix Hospice is a hospice business.

What multiple did H.I.G. Capital pay for St. Croix Hospice?

15.5x EBITDA, based on disclosed deal value of $580.0M and disclosed financials.

M&A TRANSACTION · 2020

St. Croix Hospice acquired by H.I.G. Capital

$580.0M· 15.5x EBITDA

Target

St. Croix Hospice

Acquirer

H.I.G. Capital

Private Equity buyer

Disclosed financials at time of acquisition

Revenue

—

EBITDA

$37.5M

Deal Value

$580.0M

EV/EBITDA

15.5x

Context

This $580.0M acquisition of St. Croix Hospice by H.I.G. Capital sits in the hospice sub-vertical. The 15.5x EBITDA multiple paid in 2020 can be compared against the population median for hospice transactions of similar size on our Hospice valuation hub. H.I.G. Capital is acquiring as a private equity buyer; see how PE acquirers typically price hospice businesses on our Hospice PE buyer-pool page.

Source

Data sourced from Press reporting. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own hospice

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the St. Croix Hospice acquisition.

Citation: ExitValue.ai. (2020). St. Croix Hospice acquired by H.I.G. Capital. https://exitvalue.ai/deals/st-croix-hospice-acquired-by-hig-capital-hc-2020-0118